An orally bioavailable, proprietary combination of four agents with potential antineoplastic activity. Although the four agents and their exact mechanisms of action are not publicly known, the components of SM-88 appear, upon oral administration, to work synergistically to increase the amount of free radicals in cancer cells, thereby inducing oxidative stress and selective killing of the cancer cells. Check for active clinical trials using this agent. (NCI Thesaurus)
Related Posts
Recent Posts
